SOPH – sophia genetics sa - ordinary shares (US:NASDAQ)
Stock Stats
News
Looking At The Narrative For SOPHiA GENETICS After The Latest Price Target Shift [Yahoo! Finance]
SOPHiA GENETICS (NASDAQ:SOPH) had its "buy" rating reaffirmed by analysts at Guggenheim.
SOPHiA GENETICS (NASDAQ:SOPH) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
SOPHiA GENETICS verstrekt voorlopige financiële resultaten voor het vierde kwartaal en het volledige jaar 2025, geeft richtsnoeren voor 2026 en kondigt overgangsplan voor de directie aan
Form 6-K SOPHiA GENETICS SA For: Jan 28
Form 144 SOPHiA GENETICS SA Filed by: Camblong Jurgi
Form 144 SOPHiA GENETICS SA Filed by: Camblong Jurgi
Form 144 SOPHiA GENETICS SA Filed by: Muken Ross
Form 144 SOPHiA GENETICS SA Filed by: Xu Zhenyu
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.